Demanding actual scientific proof before having Americans line up for endless shots, the Trump administration has finally put the brakes on endless COVID boosters.
Federal health officials are shifting gears in what can only be described as a victory for scientific rigor over pharmaceutical profits.
They have announced they will no longer approve annual COVID-19 vaccinations for healthy younger adults and children.
Instead, they will restrict regular access to seniors and those with legitimate health risks.
The policy change represents a dramatic shift from the previous administration’s approach, which had been treating COVID vaccines like seasonal flu shots.
This means boosters had to be updated every year and were recommended for virtually everyone.
Now, vaccine manufacturers will need to conduct large, lengthy studies to prove their products actually provide meaningful benefits to healthy populations.
This sensible policy shift should come as no surprise to those who followed Robert F. Kennedy Jr.’s appointment as Health Secretary.
Kennedy has long questioned the pharmaceutical industry’s outsized influence on public health policy, and this move signals his commitment to challenging the status quo.
The Food and Drug Administration’s new guidance specifically requires studying non-high-risk individuals for at least six months to assess actual vaccine benefits.
This marks a dramatic departure from the emergency authorization rush that characterized the initial vaccine rollout.
FDA commissioner Martin Makary described the approach as a “compromise” that allows continued protection for truly vulnerable populations.
Dr. Vinay Prasad, who has been questioning the one-size-fits-all booster approach, perfectly articulated the issue.
“For many Americans we simply do not know the answer as to whether or not they should be getting the seventh or eighth or ninth or tenth COVID-19 booster,” the doctor said.
Makary and Prasad issued a joint statement exposing the previous approach’s lack of scientific rigor.
They said, “We simply don’t know whether a healthy 52-year-old woman with a normal BMI who has had Covid-19 three times and has received six previous doses of a Covid-19 vaccine will benefit from the seventh dose.”
The announcement has triggered uproar from the medical establishment. The American Academy of Pediatrics has expressed concerns about limiting parental “choice.”
Dr. Sean O’Leary lamented that without automatic approval and insurance coverage, parents might not be able to give their healthy children yet another barely-tested vaccine.
“If the vaccine were no longer available or covered by insurance, it will take the choice away from families who wish to protect their children from COVID-19, especially among families already facing barriers to care,” he said.
